1. Home
  2. CDMO vs EYE Comparison

CDMO vs EYE Comparison

Compare CDMO & EYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDMO
  • EYE
  • Stock Information
  • Founded
  • CDMO 1981
  • EYE 1990
  • Country
  • CDMO United States
  • EYE United States
  • Employees
  • CDMO N/A
  • EYE N/A
  • Industry
  • CDMO Biotechnology: Pharmaceutical Preparations
  • EYE Ophthalmic Goods
  • Sector
  • CDMO Health Care
  • EYE Health Care
  • Exchange
  • CDMO Nasdaq
  • EYE Nasdaq
  • Market Cap
  • CDMO 793.8M
  • EYE 830.0M
  • IPO Year
  • CDMO N/A
  • EYE 2017
  • Fundamental
  • Price
  • CDMO $12.39
  • EYE $10.80
  • Analyst Decision
  • CDMO Hold
  • EYE Buy
  • Analyst Count
  • CDMO 3
  • EYE 4
  • Target Price
  • CDMO $12.25
  • EYE $13.50
  • AVG Volume (30 Days)
  • CDMO 1.3M
  • EYE 1.4M
  • Earning Date
  • CDMO 12-10-2024
  • EYE 02-25-2025
  • Dividend Yield
  • CDMO N/A
  • EYE N/A
  • EPS Growth
  • CDMO N/A
  • EYE N/A
  • EPS
  • CDMO N/A
  • EYE N/A
  • Revenue
  • CDMO $150,445,000.00
  • EYE $2,177,092,000.00
  • Revenue This Year
  • CDMO $19.05
  • EYE N/A
  • Revenue Next Year
  • CDMO $20.88
  • EYE $2.80
  • P/E Ratio
  • CDMO N/A
  • EYE N/A
  • Revenue Growth
  • CDMO 6.75
  • EYE 20.66
  • 52 Week Low
  • CDMO $5.90
  • EYE $9.56
  • 52 Week High
  • CDMO $12.48
  • EYE $24.11
  • Technical
  • Relative Strength Index (RSI)
  • CDMO 61.55
  • EYE 47.88
  • Support Level
  • CDMO $12.37
  • EYE $10.57
  • Resistance Level
  • CDMO $12.45
  • EYE $11.04
  • Average True Range (ATR)
  • CDMO 0.04
  • EYE 0.40
  • MACD
  • CDMO -0.02
  • EYE 0.02
  • Stochastic Oscillator
  • CDMO 71.43
  • EYE 65.41

About CDMO Avid Bioservices Inc.

Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. Its business is organized into one reportable operating segment which is contract manufacturing and development services segment. Its services include clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The company also provides a variety of process development services including cell line development, upstream and downstream development and optimization, analytical method development, testing and characterization.

About EYE National Vision Holdings Inc.

National Vision Holdings Inc is an optical retailer in the U.S. Its product portfolio includes eyeglasses and sunglasses, contact lenses, accessories, and other products. The company has two operating segments; Owned and Host segment includes company-owned brands America's Best and Eyeglass World, In America's Best stores, vision care services are provided by optometrists or by independent professional corporations and Host operating consist of Military and Fred Meyer which provide eye exams by independent optometrists, and the Legacy segment manages the operations of, and supplies inventory and lab processing services to Legacy retail Vision Centers. It earns a majority of its revenue from the Owned and Host segment.

Share on Social Networks: